1α,25-Dihydroxyvitamin D3 Inhibits GH-induced Expression of SOCS-3 and CIS and Prolongs Growth Hormone Signaling via the Janus Kinase (JAK2)/Signal Transducers and Activators of Transcription (STAT5) System in Osteoblast-like Cells
Open Access
- 1 September 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (38) , 34879-34884
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Lack of Socs2 Expression Causes the High-Growth Phenotype in MiceGenomics, 2001
- Growth Hormone-Regulated Intracellular Signaling in UMR 106 Osteosarcoma CellsJournal of Bone and Mineral Research, 2000
- Characterization of vitamin D receptor immunoreactivity in human bone cellsBone, 2000
- The role of STAT proteins in growth hormone signalingOncogene, 2000
- STAT5 Signaling in Sexually Dimorphic Gene Expression and Growth PatternsThe American Journal of Human Genetics, 1999
- Growth Hormone Regulation of SOCS-2, SOCS-3, and CIS Messenger Ribonucleic Acid Expression in the RatEndocrinology, 1999
- Regulatory mechanisms of growth hormone secretion are sexually dimorphic.Journal of Clinical Investigation, 1998
- Growth Hormone and BoneEndocrine Reviews, 1998
- 1,25-Dihydroxyvitamin D3 Inhibits Osteocalcin Expression in Mouse through an Indirect MechanismJournal of Biological Chemistry, 1997
- Insulin like growth factor I hormonal regulation by growth hormone and by 1,25(OH)2D3 and activity on human osteoblast-like cells in short-term culturesBone, 1990